跳至主要内容
临床试验/ISRCTN04451470
ISRCTN04451470已完成未知

A randomized, bilateral, controlled, prospective study to investigate the efficacy of trans-epithelial riboflavin/ultraviolet A corneal collagen cross-linking using iontophoresis to halt the progression of keratoconus

Guy's & St Thomas' Foundation NHS Trust (UK)0 个研究点目标入组 46 人开始时间: 2013年11月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Progressive keratoconus defined by an increase in refractive astigmatism, maximum keratometry, apex power of the cone by more than 1 diopter and/or a decrease in central corneal pachymetry by 10% in the preceding 2 years
  • 2. Grade I-III keratoconus (3 mm keratometry less than 55 diopters, cone apex power less than 70 diopters, central pachymetry greater than 400 um)
  • 3. Age over 18 years

排除标准

  • 1. Advanced keratoconus (3 mm keratometry greater than 55 diopters, cone apex power greater than 70 diopters, central pachymetry less than 400 um)
  • 2. Pregnancy
  • 3. Corneal scarring
  • 4. Co-existant ocular pathology other than keratoconus
  • 5. Age less than 18 years

研究者

发起方
Guy's & St Thomas' Foundation NHS Trust (UK)

相似试验